[1]
Lin, S.; Xie, P. L.; Luo, M. M.; Li, Q.; Li, L.; Zhang, J. Z.; Zheng, Q. X.; Chen, H.; Nan, K. H. Efficiency against multidrug resistance by co-delivery of doxorubicin and curcumin with a legumain-sensitive nanocarrier. Nano Res. 2018, 11, 3619-3635.
[2]
Zeng, Q. Z.; Wen, H. B.; Wen, Q.; Chen, X. H.; Wang, Y. G.; Xuan, W. L.; Liang, J. S.; Wan, S. H. Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Biomaterials 2013, 34, 4632-4642.
[3]
Zahorowska, B.; Crowe, P. J.; Yang, J. L. Combined therapies for cancer: A review of EGFR-targeted monotherapy and combination treatment with other drugs. J. Cancer Res. Clin. Oncol. 2009, 135, 1137-1148.
[4]
Xue, X. D.; Huang, Y.; Bo, R. N.; Jia, B.; Wu, H.; Yuan, Y.; Wang, Z. L.; Ma, Z.; Jing, D.; Xu, X. B. et al. Trojan horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat. Commun. 2018, 9, 3653.
[5]
Guo, L. R.; Yan, D. D.; Yang, D. F.; Li, Y. L.; Wang, X. D.; Zalewski, O.; Yan, B. F.; Lu, W. Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano 2014, 8, 5670-5681.
[6]
Al-Lazikani, B.; Banerji, U.; Workman, P. Combinatorial drug therapy for cancer in the post-genomic era. Nat. Biotechnol. 2012, 30, 679-692.
[7]
Baxevanis, C. N.; Perez, S. A.; Papamichail, M. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Cancer Immunol., Immunother 2009, 58, 317-324.
[8]
Zhang, H.; Hollis, C. P.; Zhang, Q.; Li, T. L. Preparation and antitumor study of camptothecin nanocrystals. Int. J. Pharm. 2011, 415, 293-300.
[9]
Sun, B.; Taha, M. S.; Ramsey, B.; Torregrosa-Allen, S.; Elzey, B. D.; Yeo, Y. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals. J. Controlled Release 2016, 235, 91-98.
[10]
Lin, Z. Q.; Gao, W.; Hu, H. X.; Ma, K.; He, B.; Dai, W. B.; Wang, X. Q.; Wang, J. C.; Zhang, X.; Zhang, Q. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J. Controlled Release 2014, 174, 161-170.
[11]
Yuan, Y.; He, Y. X.; Bo, R. N.; Ma, Z.; Wang, Z. L.; Dong, L. L.; Lin, T. Y.; Xue, X. D.; Li, Y. P. A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging. Nanoscale 2018, 10, 21634-21639.
[12]
Wang, Z. J.; Li, J.; Cho, J.; Malik, A. B. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat. Nanotechnol. 2014, 9, 204-210.
[13]
Chen, Q.; Liu, Z. Albumin carriers for cancer theranostics: A conventional platform with new promise. Adv. Mater. 2016, 28, 10557-10566.
[14]
Lovell, J. F.; Jin, C. S.; Huynh, E.; Jin, H. L.; Kim, C.; Rubinstein, J. L.; Chan, W. C. W.; Cao, W. G.; Wang, L. V.; Zheng, G. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 2011, 10, 324-332.
[15]
Mikhaylov, G.; Mikac, U.; Magaeva, A. A.; Itin, V. I.; Naiden, E. P.; Psakhye, I.; Babes, L.; Reinheckel, T.; Peters, C.; Zeiser, R. et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat. Nanotechnol. 2011, 6, 594-602.
[16]
Li, Y. P.; Lin, T. Y.; Luo, Y.; Liu, Q. Q.; Xiao, W. W.; Guo, W. C.; Lac, D.; Zhang, H. Y.; Feng, C. H.; Wachsmann-Hogiu, S. et al. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. Nat. Commun. 2014, 5, 4712.
[17]
Yang, X. X.; Xue, X. D.; Luo, Y.; Lin, T. Y.; Zhang, H. Y.; Lac, D.; Xiao, K.; He, Y. X.; Jia, B.; Lam, K. S. et al. Sub-100 nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy. J. Controlled Release 2017, 261, 297-306.
[18]
Li, Y. P.; Xiao, W. W.; Xiao, K.; Berti, L.; Luo, J. T.; Tseng, H. P.; Fung, G.; Lam, K. S. Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic ph values and cis-diols. Angew. Chem., Int. Ed. 2012, 51, 2864-2869.
[19]
Zhang, M.; Song, C. C.; Su, S.; Du, F. S.; Li, Z. C. Ros-activated ratiometric fluorescent polymeric nanoparticles for self-reporting drug delivery. ACS Appl. Mater. Interfaces 2018, 10, 7798-7810.
[20]
Wang, Z. L.; Xue, X. D.; He, Y. X.; Lu, Z. W.; Jia, B.; Wu, H.; Yuan, Y.; Huang, Y.; Wang, H.; Lu, H. W. et al. Novel redox-responsive polymeric magnetosomes with tunable magnetic resonance property for in vivo drug release visualization and dual-modal cancer therapy. Adv. Funct. Mater. 2018, 28, 1802159.
[21]
Xue, X. D.; Huang, Y.; Wang, X. S.; Wang, Z. L.; Carney, R. P.; Li, X. C.; Yuan, Y.; He, Y. X.; Lin, T. Y.; Li, Y. P. Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy. Biomaterials 2018, 161, 203-215.
[22]
Correia, A.; Shahbazi, M. A.; Mäkilä, E.; Almeida, S.; Salonen, J.; Hirvonen, J.; Santos, H. A. Cyclodextrin-modified porous silicon nanoparticles for efficient sustained drug delivery and proliferation inhibition of breast cancer cells. ACS Appl. Mater. Interfaces 2015, 7, 23197-23204.
[23]
Sierpe, R.; Lang, E.; Jara, P.; Guerrero, A. R.; Chornik, B.; Kogan, M. J.; Yutronic, N. Gold nanoparticles interacting with β-cyclodextrin- phenylethylamine inclusion complex: A ternary system for photothermal drug release. ACS Appl. Mater. Interfaces 2015, 7, 15177-15188.
[24]
Liu, Z. H.; Jiao, Y. P.; Wang, Y. F.; Zhou, C. R.; Zhang, Z. Y. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 2008, 60, 1650-1662.
[25]
Chidambaram, M.; Manavalan, R.; Kathiresan, K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 2011, 14, 67-77.
[26]
Cai, K. M.; He, X.; Song, Z. Y.; Yin, Q.; Zhang, Y. F.; Uckun, F. M.; Jiang, C.; Cheng, J. J. Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. J. Am. Chem. Soc. 2015, 137, 3458-3461.
[27]
Zheng, X. H.; Li, Z. S.; Chen, L.; Xie, Z. G.; Jing, X. B. Self-assembly of porphyrin-paclitaxel conjugates into nanomedicines: Enhanced cytotoxicity due to endosomal escape. Chem.—Asian J. 2016, 11, 1780-1784.
[28]
Lu, K. D.; He, C. B.; Guo, N. N.; Chan, C.; Ni, K. Y.; Lan, G. X.; Tang, H. D.; Pelizzari, C.; Fu, Y. X.; Spiotto, M. T. et al. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal- organic frameworks enhances checkpoint blockade immunotherapy. Nat. Biomed. Eng. 2018, 2, 600-610.
[29]
Yu, B.; Goel, S.; Ni, D. L.; Ellison, P. A.; Siamof, C. M.; Jiang, D. W.; Cheng, L.; Kang, L.; Yu, F. Q.; Liu, Z. et al. Reassembly of 89Zr-labeled cancer cell membranes into multicompartment membrane-derived liposomes for PET-trackable tumor-targeted theranostics. Adv. Mater. 2018, 30, 1704934.
[30]
Cheng, Y. J.; Zhang, A. Q.; Hu, J. J.; He, F.; Zeng, X.; Zhang, X. Z. Multifunctional peptide-amphiphile end-capped mesoporous silica nanoparticles for tumor targeting drug delivery. ACS Appl. Mater. Interfaces 2017, 9, 2093-2103.
[31]
Pommier, Y. Topoisomerase I inhibitors: Camptothecins and beyond. Nat. Rev. Cancer 2006, 6, 789-802.
[32]
Ragàs, X.; Jiménez-Banzo, A.; Sánchez-García, D.; Batllori, X.; Nonell, S. Singlet oxygen photosensitisation by the fluorescent probe singlet oxygen sensor green®. Chem. Commun. 2009, 2920-2922.
[33]
Xue, X. D.; Zhao, Y. Y.; Dai, L. R.; Zhang, X.; Hao, X. H.; Zhang, C. Q.; Huo, S. D.; Liu, J.; Liu, C.; Kumar, A. et al. Spatiotemporal drug release visualized through a drug delivery system with tunable aggregation-induced emission. Adv. Mater. 2014, 26, 712-717.
[34]
Yu, Y.; Feng, C.; Hong, Y. N.; Liu, J. Z.; Chen, S. J.; Ng, K. M.; Luo, K. Q.; Tang, B. Z. Cytophilic fluorescent bioprobes for long-term cell tracking. Adv. Mater. 2011, 23, 3298-3302.
[35]
Morris, W.; Volosskiy, B.; Demir, S.; Gándara, F.; McGrier, P. L.; Furukawa, H.; Cascio, D.; Stoddart, J. F.; Yaghi, O. M. Synthesis, structure, and metalation of two new highly porous zirconium metal-organic frameworks. Inorg. Chem. 2012, 51, 6443-6445.
[36]
Liu, J.; Huang, Y. R.; Kumar, A.; Tan, A.; Jin, S. B.; Mozhi, A.; Liang, X. J. Ph-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol. Adv. 2014, 32, 693-710.
[37]
Tan, S. J.; Jana, N. R.; Gao, S. J.; Patra, P. K.; Ying, J. Y. Surface-ligand-dependent cellular interaction, subcellular localization, and cytotoxicity of polymer-coated quantum dots. Chem. Mater. 2010, 22, 2239-2247.
[38]
Naim, B.; Zbaida, D.; Dagan, S.; Kapon, R.; Reich, Z. Cargo surface hydrophobicity is sufficient to overcome the nuclear pore complex selectivity barrier. EMBO J. 2009, 28, 2697-2705.
[39]
Zhou, Y.; Sun, H. J.; Wang, F. M.; Ren, J. S.; Qu, X. G. How functional groups influence the ros generation and cytotoxicity of graphene quantum dots. Chem. Commun. 2017, 53, 10588-10591.